News
- C4 Therapeutics Presents Preclinical Data on CFT7455, a Novel IKZF1/3 Degrader for the Treatment of Hematologic Malignancies, at the AACR Annual Meeting 2021
04/10/2021 / 21:05 - GlobeNewswire
-
- ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Athenex, Inc. Investors to Secure Counsel Before Important May 3 Deadline – ATNX
04/10/2021 / 21:00 - GlobeNewswire
-
- MPLN INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against MultiPlan Corporation
04/10/2021 / 20:28 - GlobeNewswire
-
- iRhythm® Technologies Announces Conference Call to Discuss Medicare Administrative Contractor (MAC) Novitas’s Updated Rate Publication
04/10/2021 / 20:20 - GlobeNewswire
-
- ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Ontrak, Inc. Investors to Secure Counsel Before Important May 3 Deadline – OTRK
04/10/2021 / 20:00 - GlobeNewswire
-
- 24 CHILDREN FROM AROUND THE WORLD NAMED AS FINALISTS IN LIONS CLUBS INTERNATIONAL’S PEACE POSTER CONTEST
04/10/2021 / 20:00 - GlobeNewswire
-
- Brisbane 8th Grader, Joshua Wood, Takes Home the Grand Prize in Lions Clubs International Peace Essay Contest
04/10/2021 / 20:00 - GlobeNewswire
-
- Oncocyte Presents New Data at 2021 American Association for Cancer Research Annual Meeting Demonstrating Potential for Pan-Cancer Utility of DetermaIO™
04/10/2021 / 19:31 - GlobeNewswire
-
- PMV Pharma Presents Late-Breaking Preclinical Data on Lead Product Candidate PC14586 at the American Association for Cancer Research Annual Meeting 2021
04/10/2021 / 19:31 - GlobeNewswire
-
- Zentalis Pharmaceuticals Announces Promising Initial Data Presented in a Late-Breaking Session at AACR on ZN-c3, its WEE1 Inhibitor, in Patients with Advanced Solid Tumors
04/10/2021 / 19:30 - GlobeNewswire
Real-time